PL444568A1 - 4-[(2-chlorofenylo)sulfanylo]-2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidyna oraz jej zastosowanie - Google Patents

4-[(2-chlorofenylo)sulfanylo]-2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidyna oraz jej zastosowanie Download PDF

Info

Publication number
PL444568A1
PL444568A1 PL444568A PL44456823A PL444568A1 PL 444568 A1 PL444568 A1 PL 444568A1 PL 444568 A PL444568 A PL 444568A PL 44456823 A PL44456823 A PL 44456823A PL 444568 A1 PL444568 A1 PL 444568A1
Authority
PL
Poland
Prior art keywords
sulfanyl
pyrido
ethenyl
chlorophenyl
methoxyphenyl
Prior art date
Application number
PL444568A
Other languages
English (en)
Other versions
PL246645B1 (pl
Inventor
Katarzyna Malarz
Patrycja Rawicka
Jacek Mularski
Anna Mrozek-Wilczkiewicz
Original Assignee
Uniwersytet Śląski W Katowicach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Śląski W Katowicach filed Critical Uniwersytet Śląski W Katowicach
Priority to PL444568A priority Critical patent/PL246645B1/pl
Publication of PL444568A1 publication Critical patent/PL444568A1/pl
Publication of PL246645B1 publication Critical patent/PL246645B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1018—Heterocyclic compounds
    • C09K2211/1025—Heterocyclic compounds characterised by ligands
    • C09K2211/1059—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest 4-[(2chlorofenylo)sulfanylo]-2-[(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidyna oraz jej zastosowanie jako barwnika fluorescencyjnego do barwienia biologicznych struktur komórkowych, korzystnie do barwienia błoniastych struktur komórkowych, najkorzystniej do barwienia błoniastych struktur komórkowych nowotworów nabłonkowych płuc lub błoniastych struktur komórkowych nowotworów mózgu.
PL444568A 2023-04-25 2023-04-25 4-[(2-chlorofenylo)sulfanylo]-2-[(E)-2-(2-metoksyfenylo)etenylo] pirydo[2,3-d]pirymidyna oraz jej zastosowanie PL246645B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL444568A PL246645B1 (pl) 2023-04-25 2023-04-25 4-[(2-chlorofenylo)sulfanylo]-2-[(E)-2-(2-metoksyfenylo)etenylo] pirydo[2,3-d]pirymidyna oraz jej zastosowanie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL444568A PL246645B1 (pl) 2023-04-25 2023-04-25 4-[(2-chlorofenylo)sulfanylo]-2-[(E)-2-(2-metoksyfenylo)etenylo] pirydo[2,3-d]pirymidyna oraz jej zastosowanie

Publications (2)

Publication Number Publication Date
PL444568A1 true PL444568A1 (pl) 2024-10-28
PL246645B1 PL246645B1 (pl) 2025-02-17

Family

ID=93289650

Family Applications (1)

Application Number Title Priority Date Filing Date
PL444568A PL246645B1 (pl) 2023-04-25 2023-04-25 4-[(2-chlorofenylo)sulfanylo]-2-[(E)-2-(2-metoksyfenylo)etenylo] pirydo[2,3-d]pirymidyna oraz jej zastosowanie

Country Status (1)

Country Link
PL (1) PL246645B1 (pl)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017014601A1 (ko) * 2015-07-23 2017-01-26 서울대학교 산학협력단 인돌리지노[3,2-ｃ]퀴놀린계 형광 프로브
PL233179B1 (pl) * 2016-10-31 2019-09-30 Univ Slaski Nowe zastosowanie pochodnych para-iminostyrylochinoliny

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017014601A1 (ko) * 2015-07-23 2017-01-26 서울대학교 산학협력단 인돌리지노[3,2-ｃ]퀴놀린계 형광 프로브
PL233179B1 (pl) * 2016-10-31 2019-09-30 Univ Slaski Nowe zastosowanie pochodnych para-iminostyrylochinoliny

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BARBARA CZAPLIŃSKA I IN.: "Scientific Reports 2019, 9:15304", „ACID SELECTIVE PRO-DYE FOR CELLULAR COMPARTMENTS" *

Also Published As

Publication number Publication date
PL246645B1 (pl) 2025-02-17

Similar Documents

Publication Publication Date Title
CA3199005A1 (en) Fgfr inhibitors and methods of making and using the same
ES2542059T3 (es) Nuevos anticuerpos que inhiben la dimerización de c-Met y sus utilizaciones
PE20220807A1 (es) Nuevos inhibidores de egfr
EP4247369A4 (en) SPIROCYCLIC-SUBSTITUTED 6,7-DIHYDRO-PYRANO[2,3-D]PYRIMIDINE INHIBITORS OF THE KRAS G12C MUTANT
PE20210405A1 (es) Derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona y su uso en el tratamiento de enfermedades dependientes de la proteina con dedos de zinc 2 de la familia ikaros (ikzf2)
EA202190442A1 (ru) СОЕДИНЕНИЯ 1H-ПИРАЗОЛО[4,3-d]ПИРИМИДИНА В КАЧЕСТВЕ АГОНИСТОВ TOLL-ПОДОБНОГО РЕЦЕПТОРА 7 (TLR7), СПОСОБЫ И ИХ ПРИМЕНЕНИЯ
TR200001312T2 (tr) Benzotiyazol protein tirozin kinaz önleyicileri.
PE20211388A1 (es) Compuestos
PE20091320A1 (es) Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapautica
BRPI0821743B8 (pt) derivados de piridazinona, e seu uso
AR119997A1 (es) Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5 / klk7 y métodos de uso
MY209048A (en) Pyrrolotriazine derivatives for treating kit- and pdgfra-mediated diseases
WO2022115388A8 (en) Polymer dyes
MX386700B (es) Inhibidores de la tirosina quinasa de bruton y metodos de su uso.
EA201992147A1 (ru) Ингибиторы тирозинкиназы брутона
PL444568A1 (pl) 4-[(2-chlorofenylo)sulfanylo]-2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidyna oraz jej zastosowanie
BR112021023794A2 (pt) Agente de direcionamento de antígeno, molécula de ácido nucleico isolada, composição farmacêutica, célula citotóxica, e, métodos para produzir uma célula citotóxica, para realizar uma terapia celular adotiva, para realizar uma imunoterapia e para detectar câncer em um sujeito mamífero
EA200801001A1 (ru) Соединения, которые обладают активностью по отношению к рецепторам м, и их применения в медицине
CL2021002667A1 (es) Formas cristalinas de 5-bromo-2,6-di(1h -pirazol-1-il)pirimidin-4amina y nuevas sales (divisional solicitud n° 201903468).
PL444571A1 (pl) 2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidino-4-ylo-4-metylobenzeno-1-sulfonian i jego zastosowanie
PE20181895A1 (es) Compuestos de cinnolin-4-amina y su uso en el tratamiento del cancer
AR057961A1 (es) Derivados de pirrolopirimidinas con actividad inhibitoria de receptor de tirosina quinasa. composiciones farmaceuticas.
TWD232341S (zh) 智慧型眼鏡
CN104155167A (zh) 低背景的P16-INK4a染色试剂盒及其应用方法
EA202190695A1 (ru) Композиция поверхностно-активных веществ и ее применение